Trials / Terminated
TerminatedNCT00111488
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the Randomized Study of Surgical Ablation with Microwave Energy for the Treatment of Atrial Fibrillation (RESOLVE-AF) trial is to determine the safety and effectiveness of the Guidant FLEX® Microwave Surgical Ablation System in the treatment of permanent atrial fibrillation (AF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Flex 4 and Generator |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2005-05-23
- Last updated
- 2016-01-06
Locations
21 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00111488. Inclusion in this directory is not an endorsement.